I joined the School of Pharmacy's Department of Medicines Management in 2009, having previously worked within research and regulatory affair functions in the pharmaceutical industry.

Stratford R, McKelvie ND, Hughes NJ, Aldred E, Wiseman C, Curtis J, Bellaby T, Bentley M, Hindle Z, Brennan FR, Chatfield SN, Dougan G, Khan SA. 2005. Optimization of Salmonella enterica serovar typhi DeltaaroC DeltassaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters. Infect Immun, vol. 73(1), 362-368. link> doi> McKelvie ND, Stratford R, Wu T, Bellaby T, Aldred E, Hughes NJ, Chatfield SN, Pickard D, Hale C, Dougan G, Khan SA. 2004. Expression of heterologous antigens in Salmonella Typhimurium vaccine vectors using the in vivo-inducible, SPI-2 promoter, ssaG. Vaccine, vol. 22(25-26), 3243-3255. link> doi> van Vliet AHM, Stoof J, Vlasblom R, Wainwright SA, Hughes NJ, Kelly DJ, Bereswill S, Bijlsma JJE, Hoogenboezem T, Vandenbroucke-Grauls CMJE, Kist M, Kuipers EJ, Kusters JG. 2002. The role of the ferric uptake regulator (Fur) in regulation of Helicobacter pylori iron uptake. HELICOBACTER, vol. 7(4), 237-244. link> doi> Sisson G, Goodwin A, Raudonikiene A, Hughes NJ, Mukhopadhyay AK, Berg DE, Hoffman PS. 2002. Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 46(7), 2116-2123. link> doi> Bijlsma JJE, Waidner B, van Vliet AHM, Hughes NJ, Hag S, Bereswill S, Kelly DJ, Vandenbroucke-Grauls CMJE, Kist M, Kusters JG. 2002. The Helicobacter pylori homologue of the ferric uptake regulator is involved in acid resistance. INFECTION AND IMMUNITY, vol. 70(2), 606-611. link> doi>